Abstract
s1 October 1964Coccidioidomycosis.William L. Hewitt, M.D., F.A.C.P.William L. Hewitt, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-61-4-807_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCoccidioidomycosis starts as an acute primary pulmonary infection that is asymptomatic in over 60% of all cases. Its symptomatic form may vary from an influenza-like illness to severe pneumonia. Healing may follow the primary infection, residuals may persist or dissemination may occur. The only successful chemotherapy for coccidioidomycosis is amphotericin B. Meningitis may be maintained in prolonged remission by long continued, periodic intracathecal treatment. The nephrotoxicity of amphotericin is the greatest limiting factor in chemotherapy.... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Los Angeles, Calif. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 October 1964Volume 61, Issue 4Page: 807-807KeywordsAmphotericinChemotherapyCoccidioidomycosisMeningitisPneumoniaPulmonary diseases Issue Published: 1 October 1964 PDF DownloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
